Highlights September 2021

Durable cell and gene therapies are here. Paying for Cures in the MIT NEWDIGS FoCUS Project is your source for thoughtful, thorough, and inclusive strategies to grapple with the emerging challenges of making them accessible and sustainable.

Paying for Cures: Actions you can take today

In this panel discussion, leaders across the stakeholder spectrum discuss practical steps self-insured employers can take today to make the most of new cell and gene therapies.

In Context

Self-insured employers workshop

In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and potential solutions presented by new cell and gene therapies.

In our event archive you can see presentations framing the challenges and responses, as well as other discussions about stop loss coverage implications and emerging commercial solutions.

Visit the workshop archive

Deep dive

Precision Financing Strategies

Durable therapies create three financial challenges: Payment timing, therapeutic performance risk, and actuarial risk. The NEWDIGS FoCUS consortium has worked to address the need for new, innovative financing and reimbursement models for durable/potentially curative therapies in the US to ensure patient access and sustainability for all stakeholders.

Called Precision Financing Solutions, our innovative and evolving recommendations can help self-insured employers evaluate their risks and explore combinations of solutions to meet the challenges they face.

Get the Precision Financing Solutions white paper

Hands-on

Paying for Cures Toolkit

The FoCUS Project at MIT NEWDIGS has developed this Toolkit as a resource for practitioners facing the financial challenges of offering, choosing, reimbursing or supporting an advanced durable therapy.

Use the toolkit to assess your situation, survey potential solutions, and start planning for success.

Open the Toolkit

The Global Block element was passed a non Global Block ID.

Paying for Cures is an initiative of the FoCUS Project at MIT

FoCUS seeks to collaboratively address the need for new, innovative financing and reimbursement models for durable therapies that ensure patient access and sustainability for all stakeholders. This multi-stakeholder effort unites developers, providers, regulators, patient advocacy groups, payers from all segments of the US healthcare system, and academics working in healthcare policy, financing, and reimbursement.

FoCUS research and design

Engaged cross-sector, multi-stakeholder group to identify challenges and cooperatively design sustainable solutions
Analyzed drug pipeline to understand scale of the challenge
Described system of “Cure Archetypes” and how different kinds of healthcare payers can support them
Designed and served as a catalyst for Precision Financing pilots to test real-world application

MIT Center for Biomedical Innovation
NEWDIGS Initiative
Massachusetts Institute of Technology
E19–604
77 Massachusetts Avenue
Cambridge, MA 02139

newdigs@mit.edu
Phone: 617-324-9640
Fax: 617-253-0687